The chart below ... at least until their patents expire in 2037, and that this dominance consistently generates, according to their recent earnings reports, free-cash-flow over $1 billion per ...

today announced the launch of its patent-pending“Copy to Chart” feature. This innovative tool is set to transform how aspiring traders learn technical analysis by making expert analysis ...

Pfizer and BioNTech had filed their lawsuit in September 2022 over patents relating to messenger RNA (mRNA) technology, which underpins Pfizer and BioNTech's COVID-19 vaccine. Tuesday's ruling ...

Pfizer, BioNTech Win Bid to Invalidate CureVac's UK COVID Vaccine Patents LONDON (Reuters) -Pfizer and its German partner BioNTech on Tuesday won their attempt to invalidate two of rival CureVac's ...

The government’s autumn budget sends a positive signal but a more comprehensive approach is required to unlock the UK’s potential, says Graeme Moore of Mewburn Ellis.

The two companies brought legal action over a repeated sequence in the messenger RNA (mRNA) used in CureVac's patents in life-saving ... be approved for use in the UK in January 2021 after the ...

A fire at a major UK shipyard has sparked concerns about whether ... the shipyard’s capability and possible flow-on effects are unknown, including the production timelines of Australia’s ...

The seventh LP from the Manchester rockers, it’s the band’s first release of new material in four years, but follows little more than a year after they secured their first-ever chart-topper ...

Lady Gaga and Gigi Perez are battling it out for the UK’s Number 1 single. Gaga currently leads the charge with industrial-pop rager Disease (1), which could become her seventh chart ...